Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01040624 · ClinicalTrials.gov registry record · NA
Docetaxel, Androgen Deprivation and Proton Therapy for High Risk Prostate Cancer
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 77
- Enrollment target
NCT01040624: Completed NA study, sponsored by University of Florida.
NCT01040624 is a NA study that has completed, run by University of Florida. The registered enrollment target is 77 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01040624, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 77 participants
- Enrollment target
Study Summary
The purpose of this study is to see what effects, good and/or bad, proton based radiation combined with low dose chemotherapy and hormonal therapy, has on patients and their cancer.
Primary Outcome
Number of participants that experienced acute grade 3 or higher, treatment-related toxicity based on CTCAE version 3.0 criteria.
Interventions
- RADIATION < 15% risk of + LN
- RADIATION > 15% risk of + LN
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2009-12 |
| Est. Completion | 2022-04-11 |
| Phase | NA |
What the finished NCT01040624 record still lists
NCT01040624 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 77 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which < 15% risk of + LN is the first listed.
NCT01040624 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01040624 about?
NCT01040624 is a clinical study titled "Docetaxel, Androgen Deprivation and Proton Therapy for High Risk Prostate Cancer". The purpose of this study is to see what effects, good and/or bad, proton based radiation combined with low dose chemotherapy and hormonal therapy, has on patients and their cancer.
What is the current status of trial NCT01040624?
This trial is currently completed. It is a NA study. The enrollment target is 77 participants. The study started on 2009-12. Estimated completion is 2022-04-11.
What interventions are being tested in trial NCT01040624?
The interventions under investigation include: < 15% risk of + LN (RADIATION), > 15% risk of + LN (RADIATION).
Who is sponsoring clinical trial NCT01040624?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01040624's enrollment target sits among peer trials
77 1062nd of 2000 higher than 939 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02127398 · 77 participants · Phase 2
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
- NCT04159103 · 77 participants · Phase 1
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
- NCT04683003 · 77 participants · Phase 3
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
- NCT05004116 · 77 participants · Phase 1
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia